The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
13175
Product Theater: New Data Through 2 Years from QUASAR Phase 3 Studies and Open-Label, Long-Term Extension
Date
May 5, 2025
Society: DDW
A review of key data from the QUASAR study, including new 2 year data from the open-label, long-term extension.
Supported by: Johnson & Johnson
